U07.1 – COVID-19

Discover what the ICD-10-CM code U07.1 entails, from its clinical information, if it’s billable or not, FAQs, and related ICD-10 codes by reading this short guide.

By Harriet Murray on Jun 16, 2024.

Fact Checked by Ericka Pingol.

Use Code

Table of content

U07.1 Diagnosis Code: COVID-19 Is the UO7.1 billable?U07.1 clinical information U07.1 synonyms include Other ICD-10 codes commonly used for COVID-19 FAQS

Use Code

U07.1 Diagnosis Code: COVID-19

The U07.1 is an ICD code that’s included in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), and it is used to designate “COVID-19.”

COVID-19 is one of the most significant diseases to arise recently and is the most recent health crisis in living historical memory. This disease became widespread globally in such a short amount of time that it forced most countries to go into lockdown, with people not allowed to leave their homes for any reason other than to gather essential items.

This ICD-10 code is meant for diagnosing patients with COVID-19.

Click here to view on YouTube

Is the UO7.1 billable?

Yes, the F80.2 ICD-10 code is billable and can be used to designate a patient for reimbursement purposes.

U07.1 clinical information:

COVID-19 is a type of coronavirus disease caused by the SARS-CoV-2 virus. Those who have the virus are at risk of spreading it via the following: speaking, sneezing, coughing, and exhaling. It travels in small liquid particles and can travel airborne.

Those who become afflicted with the disease develop the following symptoms:

Migraines (mild to severe)
Nausea
Loss of smell or taste (sometimes both)
Sore throat
Coughs
Fever
Chills
Muscle pain
Tiredness
Diarrhea

Some people will have all of these, and they will experience these symptoms one after the other in quick succession. Do note that at the time of this writing, several variants of this disease have emerged. The symptoms may be different depending on the variant, but these are the symptoms that are normally present. To test for this, patients will either take a Rapid Antigen or PCR Test.

Depending on the person, they might experience mild versions of these symptoms, and they will be fine with a bit of rest. However, some, especially those with respiratory illnesses, can have a more extreme experience. The symptoms are severe, and they may even die.

Antiviral medicine like Nirmatrelvir, Remdesivir, and Molnupiravir can be used to treat it. Rest will do if the disease isn’t adverse. The person should heal in just a few days or a week.

For a person to prevent getting infected with this disease, they should wear face masks where appropriate, practice good hygiene, and get vaccinated.